Ameriprise
CTIC

Ameriprise’s CTI BioPharma Corp. (DE) Common Stock CTIC Stock Holding History

Ameriprise’s Portfolio CTIC Stock Details CTIC Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2015
Q2 		– Sell
-1,726
Closed -$32K – 4174
2015
Q1 		$32K Buy
+1,726
New +$38.8K ﹤0.01% 3746
2014
Q4 		– Sell
-2,550
Closed -$62K – 5249
2014
Q3 		$62K Sell
2,550
-22
-0.9% -$572 ﹤0.01% 3903
2014
Q2 		$73K Buy
2,572
+172
+7% +$5.17K ﹤0.01% 3733
2014
Q1 		$82K Buy
+2,400
New +$82K ﹤0.01% 3589
2013
Q4 		– Sell
-702
Closed -$12K – 5839
2013
Q3 		$12K Hold
702
– – ﹤0.01% 4818
2013
Q2 		$7K Buy
+702
New +$8.23K ﹤0.01% 5036

Other funds holding CTIC

Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BIT
BlackRock Institutional Trust San Francisco, California $675B AUM 16.07% 1-Year Est. Return
BFA
BlackRock Fund Advisors San Francisco, California $542B AUM 18.13% 1-Year Est. Return
LOAMU
Lombard Odier Asset Management (USA) New York $727M AUM 41.88% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
Jane Street
Jane Street New York $1.21T AUM 78.12% 1-Year Est. Return
Northern Trust
Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return
CS
Candriam SCA Strassen, Luxembourg, Luxembourg $22.2B AUM 58.34% 1-Year Est. Return
OAM
Oxford Asset Management Oxford, United Kingdom $203M AUM 34.78% 1-Year Est. Return

Ameriprise's CTIC Position: Q2 2015 in Review

Ameriprise sold out of CTI BioPharma Corp. (DE) Common Stock (CTIC) in Q2 2015, closing a stake of 1,726 shares — an estimated $32K sold.

Ameriprise first reported a position in CTIC in Q2 2013 and held it in 6 quarters. The position peaked at $82K in Q1 2014. 95 funds tracked by Wall St. Rank hold CTIC as of Q2 2015.

  • Ameriprise reported no remaining CTI BioPharma Corp. (DE) Common Stock position as of Q2 2015 after selling out during the quarter.
  • Ameriprise sold 1,726 CTI BioPharma Corp. (DE) Common Stock shares in Q2 2015, an estimated $32K.
  • Ameriprise first reported a position in CTI BioPharma Corp. (DE) Common Stock in Q2 2013 and held it in 6 quarters.
  • Ameriprise's CTI BioPharma Corp. (DE) Common Stock position peaked at $82K in Q1 2014.
  • 95 funds tracked by Wall St. Rank held CTI BioPharma Corp. (DE) Common Stock as of Q2 2015.

Based on Ameriprise's 13F filing for Q2 2015, filed 13 Aug 2015.